These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15957944)

  • 21. A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo.
    Jones P; Altamura S; De Francesco R; Paz OG; Kinzel O; Mesiti G; Monteagudo E; Pescatore G; Rowley M; Verdirame M; Steinkühler C
    J Med Chem; 2008 Apr; 51(8):2350-3. PubMed ID: 18370373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and synthesis of a potent histone deacetylase inhibitor.
    Liu T; Kapustin G; Etzkorn FA
    J Med Chem; 2007 May; 50(9):2003-6. PubMed ID: 17419603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of HDAC inhibitor FR235222-mediated IL-2 transcriptional repression in Jurkat cells.
    Matsuoka H; Fujimura T; Mori H; Aramori I; Mutoh S
    Int Immunopharmacol; 2007 Nov; 7(11):1422-32. PubMed ID: 17761346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and campaign synthesis of piperidine- and thiazole-based histone deacetylase inhibitors.
    Andrews DM; Stokes ES; Carr GR; Matusiak ZS; Roberts CA; Waring MJ; Brady MC; Chresta CM; East SJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2580-4. PubMed ID: 18378449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total synthesis of stephanotic acid methyl ester.
    Bentley DJ; Slawin AM; Moody CJ
    Org Lett; 2006 May; 8(10):1975-8. PubMed ID: 16671760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity relationships of aryloxyalkanoic acid hydroxyamides as potent inhibitors of histone deacetylase.
    Marson CM; Mahadevan T; Dines J; Sengmany S; Morrell JM; Alao JP; Joel SP; Vigushin DM; Charles Coombes R
    Bioorg Med Chem Lett; 2007 Jan; 17(1):136-41. PubMed ID: 17046252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors.
    Shinji C; Maeda S; Imai K; Yoshida M; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2006 Nov; 14(22):7625-51. PubMed ID: 16877001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and stereochemical assignment of brasilibactin A.
    Mitchell JM; Shaw JT
    Org Lett; 2007 Apr; 9(9):1679-81. PubMed ID: 17397172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and campaign synthesis of pyridine-based histone deacetylase inhibitors.
    Andrews DM; Gibson KM; Graham MA; Matusiak ZS; Roberts CA; Stokes ES; Brady MC; Chresta CM
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2525-9. PubMed ID: 18378451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HC-toxin.
    Walton JD
    Phytochemistry; 2006 Jul; 67(14):1406-13. PubMed ID: 16839576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total synthesis of cryptophycin analogues via a scaffold approach.
    McCubbin JA; Maddess ML; Lautens M
    Org Lett; 2006 Jul; 8(14):2993-6. PubMed ID: 16805535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of immunosuppressive agent DZ2002 and its stereoisomers.
    Zhang YM; Ding Y; Tang W; Luo W; Gu M; Lu W; Tang J; Zuo JP; Nan FJ
    Bioorg Med Chem; 2008 Oct; 16(20):9212-6. PubMed ID: 18815049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic tetrapeptides with thioacetate tails or intramolecular disulfide bridge as potent inhibitors of histone deacetylases.
    Hoque MA; Arai T; Nishino N; Kim HJ; Ito A; Yoshida M
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6770-2. PubMed ID: 23021104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic study of the synthesis of macrocyclic dipeptide beta-turn mimics possessing 8-, 9-, and 10- membered rings by ring-closing metathesis.
    Kaul R; Surprenant S; Lubell WD
    J Org Chem; 2005 May; 70(10):3838-44. PubMed ID: 15876068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total synthesis of spiruchostatin B, a potent histone deacetylase inhibitor, from a microorganism.
    Takizawa T; Watanabe K; Narita K; Oguchi T; Abe H; Katoh T
    Chem Commun (Camb); 2008 Apr; (14):1677-9. PubMed ID: 18368162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereoselective synthesis of the gamma-lactam hydrolysate of the thiopeptide cyclothiazomycin.
    Bagley MC; Xiong X
    Org Lett; 2004 Sep; 6(19):3401-4. PubMed ID: 15355062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppressive activity of threonine-containing analogues of cyclolinopeptide A.
    Siemion IZ; Cebrat M; Lisowski M; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1992; 40(5-6):257-61. PubMed ID: 1340179
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group.
    Chen PC; Patil V; Guerrant W; Green P; Oyelere AK
    Bioorg Med Chem; 2008 May; 16(9):4839-53. PubMed ID: 18397827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analogues of cyclolinopeptide A containing alpha-hydroxymethyl amino acid residues.
    Zubrzak P; Banaś A; Kaczmarek K; Leplawy MT; Sochacki M; Kowalski ML; Szkudlińska B; Zabrocki J; Di Lello P; Isernia C; Saviano M; Pedone C; Benedetti E
    Biopolymers; 2005; 80(2-3):347-56. PubMed ID: 15614802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thalassospiramides A and B, immunosuppressive peptides from the marine bacterium Thalassospira sp.
    Oh DC; Strangman WK; Kauffman CA; Jensen PR; Fenical W
    Org Lett; 2007 Apr; 9(8):1525-8. PubMed ID: 17373804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.